Will Stem Cell Biology Generate New Therapies for Parkinson's Disease?
Authors:
- Ron McKayRMRon McKay
- Raja KittappaRKRaja Kittappa
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Assessing fetal nerve cell grafts in Parkinson's diseaseNature Medicine, 2008
- Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's diseaseNature Medicine, 2008
- Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagationNature Medicine, 2008
- The foxa2 Gene Controls the Birth and Spontaneous Degeneration of Dopamine Neurons in Old AgePLOS Biology, 2007
- Control of microglial neurotoxicity by the fractalkine receptorNature Neuroscience, 2006
- ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosisNature Genetics, 2006
- Pathological Cell-Cell Interactions Elicited by a Neuropathogenic Form of Mutant Huntingtin Contribute to Cortical Pathogenesis in HD MiceNeuron, 2005
- Inflammation and the Degenerative Diseases of AgingAnnals of the New York Academy of Sciences, 2004
- Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's diseaseNature, 2002
- Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposureAnnals of Neurology, 1999